Mirati Therapeutics, Inc. 4
4 · Mirati Therapeutics, Inc. · Filed Mar 17, 2016
Insider Transaction Report
Form 4
Boxer Asset Management Inc.
10% Owner
Transactions
- Other
Common Stock
2016-03-17−375,298→ 0 total
Holdings
- 757,935(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Reflects 375,298 shares received by Boxer Asset Management Inc. ("Boxer Management") in connection with the transfer by Boxer Capital, LLC ("Boxer Capital") on March 16, 2016 of 474,158 shares of the common stock of the issuer, pro rata for no consideration as part of an internal reorganization that was exempt under Rule 16a-9. On March 17, 2016, Boxer Management transferred 375,298 shares of the common stock of the issuer to Braslyn Ltd. ("Braslyn") for no consideration as part of an internal reorganization.
- [F2]These securities are owned directly by Boxer Management, who may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) the reporting person, (iii) MVA Investors, LLC, (iv) Braslyn, (v) Joe Lewis, (vi) Christopher Fuglesang, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Neil Reisman, (x) Shehan B. Dissanayake, (xi) Peter E. Harwin, and (xii) William N. Harwin 2012 Gift Trust F/B/O Peter Harwin.
- [F3]These securities are owned directly by Boxer Capital, and indirectly by Boxer Management and Joe Lewis, by virtue of their ownership in Boxer Capital. The reporting person disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein.